Squarepoint’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
ECM
Squarepoint's OXFD Position: Q3 2020 in Review
Squarepoint sold out of Oxford Immunotec Global (OXFD) in Q3 2020, closing a stake of 15,600 shares — an estimated $203K sold.
Squarepoint first reported a position in OXFD in Q2 2018 and held it in 9 quarters. The position peaked at $1.36M in Q4 2019. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.
- Squarepoint reported no remaining Oxford Immunotec Global position as of Q3 2020 after selling out during the quarter.
- Squarepoint sold 15,600 Oxford Immunotec Global shares in Q3 2020, an estimated $203K.
- Squarepoint first reported a position in Oxford Immunotec Global in Q2 2018 and held it in 9 quarters.
- Squarepoint's Oxford Immunotec Global position peaked at $1.36M in Q4 2019.
- 71 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q3 2020.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.